ANELLI, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 2.291
EU - Europa 540
AS - Asia 231
OC - Oceania 2
SA - Sud America 1
Totale 3.065
Nazione #
US - Stati Uniti d'America 2.281
SE - Svezia 164
CN - Cina 142
DE - Germania 131
IT - Italia 69
SG - Singapore 57
FR - Francia 52
GB - Regno Unito 43
BE - Belgio 28
FI - Finlandia 24
IR - Iran 9
UA - Ucraina 9
CA - Canada 8
VN - Vietnam 8
IN - India 5
CZ - Repubblica Ceca 4
AT - Austria 3
ID - Indonesia 3
RU - Federazione Russa 3
HK - Hong Kong 2
IE - Irlanda 2
LT - Lituania 2
RO - Romania 2
AU - Australia 1
BR - Brasile 1
DO - Repubblica Dominicana 1
HR - Croazia 1
IS - Islanda 1
JP - Giappone 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
MP - Marianne Settentrionali, isole 1
PA - Panama 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 3.065
Città #
Fairfield 315
Chandler 286
Woodbridge 257
Seattle 165
Houston 161
Ann Arbor 150
Ashburn 147
Nyköping 139
Cambridge 119
Wilmington 101
Beijing 50
Jacksonville 39
Lawrence 38
Roxbury 38
Singapore 35
New York 33
Bari 28
Brussels 28
Dearborn 26
Des Moines 25
Inglewood 25
Nanjing 24
San Diego 19
Paris 15
Munich 14
Princeton 13
Brooklyn 11
Santa Clara 11
Redwood City 9
Boardman 8
Helsinki 8
London 8
Dong Ket 7
Hebei 7
Los Angeles 7
San Francisco 7
Ardabil 5
Nanchang 5
Shanghai 5
Changsha 4
Guangzhou 4
Hefei 4
Jinan 4
Milan 4
Shenyang 4
Tianjin 4
Toronto 4
Augusta 3
Detroit 3
Kunming 3
Leawood 3
Prescot 3
San Mateo 3
Vienna 3
Washington 3
Brno 2
Dublin 2
Haikou 2
Hounslow 2
Jiaxing 2
Kilburn 2
Markham 2
Mumbai 2
Ningbo 2
Ottawa 2
Zhengzhou 2
Acton 1
Alba 1
Belgrade 1
Bratislava 1
Can Tho 1
Central 1
Chongqing 1
Clifton 1
East Ham 1
Esslingen am Neckar 1
Flitwick 1
Florence 1
Frankfurt am Main 1
Fuzhou 1
Gostar 1
Hyderabad 1
Indiana 1
Jakarta 1
Jinhua 1
Makhachkala 1
Manduria 1
Melbourne 1
Monmouth Junction 1
Moscow 1
Nagold 1
New Delhi 1
Norwalk 1
Nürnberg 1
Oklahoma City 1
Olomouc 1
Paracambi 1
Pars 1
Pune 1
Reykjavik 1
Totale 2.500
Nome #
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors 126
Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patients 121
Early changes of articular cartilage, synovial membrane and subchondral bone in an experimental model of goat osteoarthrtitis 113
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: Results from the GISEA register 111
Two-year survival rates of anti-TNF-α therapy in psoriatic arthritis (PsA) patients with either polyarticular or oligoarticular PsA 109
Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy 109
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: Premises, perils, and perspectives 103
Management of Small Vessel Vasculitides 102
null 101
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 100
Old and new antirheumatic drugs and the risk of hepatotoxicity 98
Lipid Profile of Rheumatoid Arthritis Patients Treated with Anti-Tumor Necrosis Factor-Alpha Drugs Changes According to Disease Activity and Predicts Clinical Response 97
null 97
AB0836 Drug retention rate of the first tnf inhibitor in radiographic and non radiographic axial spondyloarthritis: data from a multicenter study 93
AB0618 A unique ultrasound pattern of adipose tissue in systemic sclerosis patients: a comparison with rheumatoid arthritis patients and healthy controls. two sides of adipose tissue involvement in systemic chronic inflammatory diseases 92
AB0065 Possible Interplay Between Serum Amyloid-A and Pro-Inflammatory Cytokines Into the Pathogenesis of Behçet's Disease 92
Lipids and atherogenic indices fluctuation in rheumatoid arthritis patients on long-term tocilizumab treatment 87
AB0041 Serum Amyloid A Stimulates The Induction of Inflammatory Mediators in Monocytes from Behçet's Disease Patients: A Proof of Concept Study 87
Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab 84
AB0452 Changes in Lipoproteins Associated with Tocilizumab Treatment Do not Influence the Atherogenic Index of Plasma of Rheumatoid Arthritis Patients: Table 1 83
Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 81
SAT0212 Pericardial Effusion Related To Systemic Sclerosis: A Possible Contribution of The Serum Levels of Adipokines and Interleukines 76
THU0153 The effect of 5-years b-dmards treatment on different 10-years cardiovascular risk scores applied in rheumatoid arthritispatients 74
SAT0216 Chest Ultrasound Signs of Interstitial Lung Disease in Systemic Sclerosis Patients: A Comparison between High Resolution Chest Computed Tomography Findings 73
EARLY CHANGES OF ARTHICULAR CARTILAGE, SYNOVIAL MEMBRANE AND SUBCHONDRAL BONE IN AN EXPERIMENTAL MODEL OF GOAT OSTEOARTHRITIS 72
FRI0110 Methotrexate monotherapy in real life: a drug survival analysis. comparison between very early arthritis and early arthritis cohorts 71
LIPID PROFILE OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ANTI-TNF-ALPHA DRUGS CHANGES ACCORDING TO DISEASE ACTIVITY RESPONSE 70
OPG-RANKL system and Osteopontin in a postmenopausal women population. ANNALS OF THE RHEUMATIC DISEASES 68
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: an observational multicentre study 63
THU0168 Relationships between body fat composition assessed with bioelectrical impedance analysis, serum adipokines and disease activity in patients with rheumatoid arthritis 62
Evaluation of Serum Levels of Adipokines and Interleukines in Pericardial Effusion Related to Systemic Sclerosis 61
OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors 60
Temporomandibular Disorders and Oral Features in Early Rheumatoid Arthritis Patients: An Observational study. 57
SAT0380 FIBROMYALGIA IS THE STRONGEST NEGATIVE PREDICTOR FOR THE ACHIEVEMENT OF EITHER REMISSION AND MINIMAL DISEASE ACTIVITY IN NAIVE PSORIATIC ARTHRITIS PATIENTS STARTING BIOLOGIC DRUGS 56
Intentional etanercept use during pregnancy for maintenance of remission in rheumatoid arthritis 49
Giant Cell Tumor of Synovial Sheath: Of Two Cases Treated with Intra-Articular Infiltration of Infliximab 49
The Impact of Biologic Drugs on High-Density Lipoprotein Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients 42
Tomographic regression of pulmonary rheumatoid nodules under baricitinib therapy 40
High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry 35
Influence of TNF- α inhibition on oxidative stress of rheumatoid arthritis patients 12
L'obésité diminue le maintien thérapeutique des traitements biologiques de seconde ligne après échec d'un anti-TNF de première ligne au cours de la polyarthrite rhumatoïde 9
Totale 3.185
Categoria #
all - tutte 13.926
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.926


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020671 0 0 0 0 63 113 125 113 114 58 58 27
2020/2021515 26 46 28 33 63 22 58 68 40 55 44 32
2021/2022358 20 23 8 13 18 31 10 19 19 30 55 112
2022/2023656 71 106 46 66 71 82 16 78 87 5 17 11
2023/2024154 8 35 10 17 15 41 2 5 0 3 2 16
2024/2025133 18 16 62 25 12 0 0 0 0 0 0 0
Totale 3.185